Insulet Corporation Stock Performance
as on July 25, 2026 at 2:15 pm IST
Day's Low
Day's High
$158.31$164.33
3.03%
Downside
0.66%
Upside
52 Week's Low
52 Week's High
$138.79$354.8814.99%
Downside
117.37%
Upside
Insulet Corporation share price movements today
- Previous Close
- $158.38
- Open
- $159.24
- Volume
- 704.7K
- Day's Low - High
- $158.31 - $164.33
- 52 Week Low - High
- $138.79 - $354.88
Insulet Corporation Historical Returns
- 1 Month Return
- + 2.96 %
- 3 Month Return
- -16.45 %
- 1 Year Return
- -45.43 %
- 3 Year Return
- -43.79 %
- 5 Year Return
- -42.73 %
Insulet Corporation Stock Fundamentals & Key Indicators
Check Insulet Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.0B
EPS (TTM)
6.4775
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.59%
PE Ratio (TTM)
38.3
Industry PE ratio
23.60857142857143
PEG Ratio
1.4446
EBITDA
602.0M
Revenue (TTM)
2.9B
Profit Margin
10.44%
Return On Equity TTM
23.00%
Insulet Corporation Stock Valuation
Track how Insulet Corporation P/E has moved over time to understand its valuation trends.
Insulet Corporation in the last 5 years
Lowest (29.80x)
June 30, 2026
Industry (23.61x)
July 25, 2026
Today (38.30x)
July 25, 2026
Highest (143.53x)
September 30, 2023
Today’s Price to Earnings Ratio: 38.30x
Insulet Corporation vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Insulet Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $11.0B | -42.73% | 38.3 | 10.44% | NA | |
| BUY | $118.6B | 21.43% | 36.38 | 13.21% | 1.09% | |
| BUY | $106.6B | -36.2% | 22.07 | 13.20% | 3.45% | |
| BUY | $48.7B | -23.38% | 45.7 | 17.39% | NA | |
| BUY | $177.1B | -16.6% | 32.23 | 11.65% | 2.4899999999999998% |
Stock Returns calculator for Insulet Corporation Stock including INR - Dollar returns
The Insulet Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Insulet Corporation investment value today
Current value as on today
₹62,878
Returns
Returns from Insulet Corporation Stock
Dollar Impact
₹6,624 (+6.62%)
Analyst Recommendation on Insulet Corporation Stock
Based on 28 analysts
82.14%
Buy
17.86%
Hold
0.00%
Sell
Based on 28 analysts, 82.14% of analysts recommend a 'BUY' rating for Insulet Corporation. Average target price of $238.22
Insulet Corporation Share Price Target
Get share price movements and forecasts by analysts on Insulet Corporation.
What analysts predicted
31.47%UPSIDE
Target Price
$238.22
Current Price
$163.26
Analyzed by
28 Analysts
Target
$238.22
Insulet Corporation target price $238.22, a slight upside of 31.47% compared to current price of $163.26. According to 28 analysts rating.
Indian Investors' Interest in Insulet Corporation Stock
Search interest for Insulet Corporation Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Insulet Corporation Quarterly Profit & Loss
All numbers in Millions USD
Insulet Corporation Annual Profit & Loss
All numbers in Millions USD
Insulet Corporation Quarterly Cash Flow
All numbers in Millions USD
Insulet Corporation Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Insulet Corporation Stock
Check out the Mutual Funds with significant holdings in Insulet Corporation.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.01622% | 505 |
Global Institutional Holdings in Insulet Corporation
Insulet Corporation News & Key Events
Today's Timeline - 06 July
Mon, 04:33 PM
-Insulet launches Omnipod 5 and Omnipod Discover in Spain, expanding its market presence in Europe.
Mon, 11:06 PM
-FDA classifies Insulet's Omnipod recall as serious due to injury reports linked to insulin delivery failures.
Tue, 01:15 AM
-Deutsche Bank initiates coverage on Insulet with a Buy rating and $190 target, citing strong growth potential.
Insights on Insulet Corporation
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Edwards Lifesciences Corp has given 3.3% return, outperforming this stock by 47.0%
- NO EFFECT
Against Peers
In the last 3 years, Insulet Corporation Common Stock has experienced a drawdown of -42.1%, however Stryker Corporation resisted the overall trend and outperformed by 32.2%
NEGATIVE IMPACTPrice Dip
In the last 6 months, PODD stock has moved down by -39.9%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 101.60M → 91.10M (in $), with an average decrease of 10.3% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 783.79M → 761.70M (in $), with an average decrease of 2.8% per quarter
About Insulet Corporation
| Organisation | Insulet Corporation |
| Headquarters | 100 Nagog Park, Acton, MA, United States, 01720 |
| Industry | Medical Devices |
| CEO | Ms. Ashley A. McEvoy |
| E-voting on shares | Click here to vote |
Key Management of Insulet Corporation
Name | Title |
|---|---|
Mr. John Wodick Kapples J.D. | Senior VP & General Counsel |
Mr. Amit Guliani | Senior VP & CTO |
Ms. Clare Trachtman | Vice President of Investor Relations |
Mr. Chuck Medovich | Senior VP and Chief Quality, Regulatory & Compliance Officer |
Mr. Philip Hildale | Senior Vice President of Sales & Customer Care |
Ms. Ashley A. McEvoy | CEO, President & Director |
Ms. Flavia H. Pease | Executive VP & CFO |
Ms. Angela Geryak Wiczek | Senior Director of Corporate Communications |
Mr. Eric Benjamin | Executive VP & COO |
Mr. Prem Singh | Senior Vice President of Global Operations |
FAQs
What is Insulet Corporation share price today?
Insulet Corporation share price today is $163.26 as on at the close of the market. Insulet Corporation share today touched a day high of $164.33 and a low of $158.31.
What is the 52 week high and 52 week low for Insulet Corporation share?
Insulet Corporation share touched a 52 week high of $354.88 on and a 52 week low of $138.79 on . Insulet Corporation stock price today i.e. is closed at $163.26,which is 54.00% down from its 52 week high and 17.63% up from its 52 week low.
What is Insulet Corporation's market capitalisation today?
Insulet Corporation market capitalisation is $0.01T as on .
How to invest in Insulet Corporation Stock (PODD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Insulet Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insulet Corporation Shares that will get you 0.0092 shares as per Insulet Corporation share price of $163.26 per share as on July 25, 2026 at 8:45 am IST.
What is the minimum amount required to buy Insulet Corporation Stock (PODD) from India?
Indian investors can start investing in Insulet Corporation (PODD) shares with as little as ₹96.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹965.52 in Insulet Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Insulet Corporation share’s latest price of $163.26 as on July 25, 2026 at 8:45 am IST, you will get 0.0613 shares of Insulet Corporation. Learn more about
fractional shares .
What are the returns that Insulet Corporation has given to Indian investors in the last 5 years?
Insulet Corporation stock has given -42.73% share price returns and 29.46% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?